MarketWatch: Cancer
Pages: 24
Publisher: Datamonitor
Date Published: March 2008
Format: PDF
Price: $200
Overview
Datamonitor’s Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the major current business issues and events, including R&D news, licensing deals, alliances and joint ventures, and regulatory decisions.
Table of Contents
This month’s highlights
Page 2 – Key Announcements
Page 2 – Cancer News Round-up
Leukemia and Lymphoma News
Page 4 – News Headlines
Page 4 – Lymphoma Update
Page 5 – Leukemia Update
Female Cancers News
Page 7 – Opinion: Abraxis BioScience: Abraxane will face strong competition in Europe
Page 8 – News Headlines
Page 8 – Breast Cancer Update
Page 9 – Ovarian Cancer Update
Other Cancers News
Page 11 – Opinion: Bayer/Onyx Pharmaceuticals: Nexavar approved for kidney cancer in Japan
Page 12 – News Headlines
Page 12 – Prostate Cancer Update
Page 13 – Colorectal Cancer Update
Page 14 – Lung Cancer Update
Company Spotlight
Page 16 – Bayer
Further Reading
Page – 22
Index
Page 23 – Pharma companies
Page 23 – Biotech companies
Page 24 – Key drugs
